Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Unknown Primary Site”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Large-scale testing (Phase 3)Looking for participantsNCT06589804
What this trial is testing

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell CarcinomaMetastatic Laryngeal Squamous Cell Carcinoma+18 more
National Cancer Institute (NCI) 158
Early research (Phase 1)Study completedNCT01643499
What this trial is testing

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the GallbladderAdenocarcinoma of Unknown Primary+37 more
University of Chicago 79
Early research (Phase 1)Looking for participantsNCT07006727
What this trial is testing

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

Who this might be right for
Small Cell Lung CarcinomaLarge Cell Neuroendocrine Carcinoma of the LungNeuroendocrine Prostate Cancer+8 more
Novartis Pharmaceuticals 116
Large-scale testing (Phase 3)Study completedNCT03258554
What this trial is testing

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Head and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma+17 more
National Cancer Institute (NCI) 196
Early research (Phase 1)Looking for participantsNCT06868433
What this trial is testing

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+20 more
Emory University
Testing effectiveness (Phase 2)Looking for participantsNCT06995508
What this trial is testing

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

Who this might be right for
Cancer-Associated AnorexiaHead and Neck Squamous Cell CarcinomaNeck Squamous Cell Carcinoma of Unknown Primary
Roswell Park Cancer Institute 66
Testing effectiveness (Phase 2)Study completedNCT00737243
What this trial is testing

Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site

Who this might be right for
Carcinoma
SCRI Development Innovations, LLC 289
Testing effectiveness (Phase 2)Study completedNCT01845337
What this trial is testing

Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine

Who this might be right for
Gastrointestinal CancerCancer of Unknown Primary SitePancreatic Cancer+1 more
University of Edinburgh 59
Testing effectiveness (Phase 2)Study completedNCT00357630
What this trial is testing

Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary

Who this might be right for
Carcinoma of Unknown PrimaryPain
Eastern Cooperative Oncology Group 52
Not applicableStudy completedNCT02966509
What this trial is testing

Engagement of Patients With Advanced Cancer

Who this might be right for
End of LifeAdvanced CancerLung Neoplasm+11 more
Stanford University 213
Testing effectiveness (Phase 2)Ended earlyNCT00696943
What this trial is testing

18F ML-10 for Early Detection of Response of Brain Metastases to SRS

Who this might be right for
Metastasis to Brain of Unknown Primary
Aposense Ltd. 1
Large-scale testing (Phase 3)UnknownNCT00022178
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

Who this might be right for
Carcinoma of Unknown Primary
The Christie NHS Foundation Trust
Testing effectiveness (Phase 2)Study completedNCT03752333
What this trial is testing

Trial of Pembrolizumab in Cancer of Unknown Primary

Who this might be right for
Cancer of Unknown Primary Site
Imperial College London 35
Not applicableLooking for participantsNCT05046444
What this trial is testing

Solving Riddles Through Sequencing

Who this might be right for
LeukemiaHematologic MalignancyRare Diseases+3 more
Munich Leukemia Laboratory 100
Not applicableUnknownNCT06100081
What this trial is testing

Real-time Targeted Fluorescence Endoscopy for Detection of the Primary Cancer Lesion in Patients With a Metastasis of Unknown Primary Tumor in the Head and Neck

Who this might be right for
Unknown Primary TumorsOropharynx Cancer
University Medical Center Groningen 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06578871
What this trial is testing

Surgery and Reducing Ionizing Radiation of the Unknown Primary

Who this might be right for
Head and Neck Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 90
Not applicableActive Not RecruitingNCT04151134
What this trial is testing

Evaluation of Tongue Base MucOsectomy & Step sErial Sectioning

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
Royal Marsden NHS Foundation Trust 100
Not applicableStudy completedNCT04750109
What this trial is testing

Carcinoma of Unknown Primary (CUP): a Comparison Across Tissue and Liquid Biomarkers

Who this might be right for
Cancer of Unknown Primary Site
The Christie NHS Foundation Trust 117
Not applicableActive Not RecruitingNCT06863870
What this trial is testing

Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma

Who this might be right for
Melanoma Neoplasms
IRCCS Azienda Ospedaliero-Universitaria di Bologna 35
Next Page
40